Anna Montanaro

Parma, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Inhibition of the Atypical Kinase WNK1 as a Therapeutic Strategy in TAL-related T-cell Acute Lymphoblastic Leukemia.

Inhibition of the Atypical Kinase WNK1 as a Therapeutic Strategy in TAL-related T-cell Acute Lymphoblastic Leukemia.

Journal: Blood

Published: June 27, 2025

Genetics of Darier's Disease: New Insights into Pathogenic Mechanisms.

Genetics of Darier's Disease: New Insights into Pathogenic Mechanisms.

Journal: Genes

Published: April 30, 2025

The endogenous T cell landscape is reshaped by CAR-T cell therapy and predicts treatment response in multiple myeloma.

The endogenous T cell landscape is reshaped by CAR-T cell therapy and predicts treatment response in multiple myeloma.

Journal: Leukemia

Published: November 26, 2024

Ex vivo drug response profiling guides therapy in a case of high-risk acute undifferentiated leukemia with PICALM::MLLT10.

Ex vivo drug response profiling guides therapy in a case of high-risk acute undifferentiated leukemia with PICALM::MLLT10.

Journal: Haematologica

Published: October 22, 2024

CD26 Is Differentially Expressed throughout the Life Cycle of Infantile Hemangiomas and Characterizes the Proliferative Phase.

CD26 Is Differentially Expressed throughout the Life Cycle of Infantile Hemangiomas and Characterizes the Proliferative Phase.

Journal: International journal of molecular sciences

Published: July 09, 2024

CAD204520 Targets NOTCH1 PEST Domain Mutations in Lymphoproliferative Disorders.

CAD204520 Targets NOTCH1 PEST Domain Mutations in Lymphoproliferative Disorders.

Journal: International journal of molecular sciences

Published: November 19, 2023

Orthogonal proteogenomic analysis identifies the druggable PA2G4-MYC axis in 3q26 AML.

Orthogonal proteogenomic analysis identifies the druggable PA2G4-MYC axis in 3q26 AML.

Journal: Nature communications

Published: February 03, 2023

Identification of an Epi-metabolic dependency on EHMT2/G9a in T-cell acute lymphoblastic leukemia.

Identification of an Epi-metabolic dependency on EHMT2/G9a in T-cell acute lymphoblastic leukemia.

Journal: Cell death & disease

Published: January 25, 2022

Venetoclax and Bortezomib in Relapsed/Refractory Early T-Cell Precursor Acute Lymphoblastic Leukemia.

Venetoclax and Bortezomib in Relapsed/Refractory Early T-Cell Precursor Acute Lymphoblastic Leukemia.

Journal: JCO precision oncology

Published: August 16, 2019

Blockade of Oncogenic NOTCH1 with the SERCA Inhibitor CAD204520 in T Cell Acute Lymphoblastic Leukemia.

Blockade of Oncogenic NOTCH1 with the SERCA Inhibitor CAD204520 in T Cell Acute Lymphoblastic Leukemia.

Journal: Cell chemical biology

Published: July 04, 2019

Showing 1-10 of 10

Last Updated: 09/26/2026